Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 10/20 | 0.44 |
| ▸ | NADK | O95544 | 1/20 | 0.43 |
| ▸ | DOT1L | Q8TEK3 | 4/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 4/20 | 0.43 |
| ▸ | PRMT3 | O60678 | 2/20 | 0.43 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.43 |
| ▸ | NNMT | P40261 | 1/20 | 0.43 |
| ▸ | PRMT9 | Q6P2P2 | 1/20 | 0.42 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.42 |
| ▸ | GNMT | Q14749 | 2/20 | 0.42 |
| ▸ | METTL3 | Q86U44 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31526263 | 0.94 | PRMT5 (0.42) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526270 | 0.91 | ADK (0.45) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526186 | 0.88 | ADK (0.58) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31570710 | 0.88 | ADK (0.47) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526255 | 0.88 | ADK (0.56) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526392 | 0.87 | ADK (0.49) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526383 | 0.87 | DOT1L (0.47) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526342 | 0.85 | ADK (0.55) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526114 | 0.85 | ADK (0.57) | ADKNADKDOT1LPRMT5PRMT3 | |
| SCHEMBL31526170 | 0.85 | ADK (0.45) | ADKNADKDOT1LPRMT5PRMT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025098545-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553080-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2025-05-14 | — | — | EP | disclosed |